Clinical Trials Logo

Other B Cell Lymphoma in Relapse clinical trials

View clinical trials related to Other B Cell Lymphoma in Relapse.

Filter by:
  • None
  • Page 1

NCT ID: NCT01435720 Active, not recruiting - Multiple Myeloma Clinical Trials

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Start date: September 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia patients when given by intravenous infusion at various doses.